# Fighting Cancer in Children Act

This bill takes money from the National Institutes of Health's main administrative office and redirects it toward pediatric cancer research and support programs. Specifically, it moves $30 million from the Office of the Director of the NIH to fund research, awareness campaigns, and support services for children with cancer. The bill also removes another $30 million from the budget entirely, which reduces overall government spending.

The practical effect is that the NIH's central leadership office would have less money to operate with, but that money would go directly toward fighting childhood cancer. This includes funding for scientific research to develop better treatments, public awareness efforts to help families recognize cancer symptoms early, and programs to support children who have survived cancer. For families dealing with pediatric cancer, this could mean more resources dedicated to finding new treatments and helping children recover. For the broader NIH, it means the director's office would need to operate with a smaller budget, though the specific services that might be affected aren't detailed in the bill.

The $30 million rescission—the money that's simply removed from the budget—is meant to help reduce the federal deficit. So while this bill prioritizes childhood cancer funding, it also attempts to offset that spending by cutting money elsewhere in the government rather than adding to the overall budget.

Fighting Cancer in Children Act

Norman, Ralph

Fighting Cancer in Children Act This bill makes funding available for research and related activities concerning pediatric cancer that are conducted or supported by the National Institutes of Health (NIH) from funds previously made available to the NIH Office of the Director. Specifically, the bill transfers unobligated funding from the NIH Office of the Director and merges it with other NIH funding for biorepositories of pediatric cancer specimens and research on pediatric cancer survivorship. The bill also rescinds additional funding that was provided to the NIH Office of the Director.